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Although > 95% of men with testicular cancer (TC) are cured, many experience 
ongoing physical and psychological effects related to diagnosis and treatment. This 
large study is the fi rst to use a validated measure of TC-specifi c quality of life 
(QOL) to assess the long-term sequelae of TC.  
 
Aims: To determine the prevalence/severity and correlates of impaired  QOL, 
psychological distress, and unmet needs in Australian TC survivors.  
 
Methods: Men who had completed active treatment for TC 0.5–5 years previously, 
showing no evidence of recurrence, were recruited from 14 Australian cancer centres. 
Participants completed a questionnaire measuring demographics, disease and 
treatment information, general (SF36v2) and TC-specifi c (EORTC QLQ-TC26) 
QOL, psychological distress (DASS21) and unmet needs (CaSUN). 
 
Results: 244 of 486 eligible TC survivors participated. Compared to age adjusted 
Australian general population norms, TC survivors an average of  2.3 years post-
treatment reported significantly higher levels of depression  
(p = 0.003, mean difference = 2.43, 95% CI 0.82, 4.04) and anxiety  
(p = 0.007, mean difference = 2.46, 95% CI 0.69, 4.24), lower mental QOL  
(p < 0.001, mean difference = −6.85 95% CI −8.47, −5.24) and marginally  
higher physical QOL (p = 0.036, mean difference = 0.99,  95%  CI 0.07,1.91). The 
most commonly reported TC-specifi c QOL issues were anxiety about cancer 
recurrence and the future generally, plus the impact of TC on sexuality and fertility. 
Almost a quarter (22–23%) of TC survivors reported unmet needs relating to these 
issues. Variables most strongly associated with outcomes were: a helpless/hopeless 
adjustment style with depression (p < 0.001,  B = 1.27, 95% CI 0.89, 1.65) and poorer 
mental QOL (p < 0.001, B = −1.23, 95% CI −1.83, −0.63); more severe treatment side  
effects with anxiety (p < 0.001, B = 0.14, 95% CI 0.09, 0.20); and more job problems 
with poorer physical QOL (p < 0.001, B = −0.12, 95% CI −0.17, −0.07). 
 
 
Conclusions:  Australian TC survivors have relatively good physical QOL, but suffer 
from ongoing impaired mental QOL and psychological distress. Effective 
management of side effects and intervention to reduce helplessness/hopelessness may 
facilitate better adjustment. 
 
 
